Northeastern Law Magazine: Summer 2022 Issue
“Shooting Pains,” “Rethinking Business As Usual,” “Active Duty” and many more stories await readers in the summer 2022 issue of Northeastern Law magazine. Read it online now!
“Shooting Pains,” “Rethinking Business As Usual,” “Active Duty” and many more stories await readers in the summer 2022 issue of Northeastern Law magazine. Read it online now!
In-game betting, which allows people to bet on specific plays during a game, is a particularly pernicious way that these companies have “deliberately engineered” the process to guarantee addicts stay hooked, says Professor Richard Daynard, president of Northeastern Law’s Public Health Advocacy Institute.
Amber Kolb ’23, winner of the ABA’s Howard C. Schwab Memorial Essay Contest, is featured in News@Northeastern! Amber’s winning essay, “Influencing a New Generation: Guardians’ Duties to Protect the Interests and Safety of Children on Social Media,” addresses the potential harms of child stardom by exploring the lack of legal protections for toddlers and tweens using the internet. #NUSLPride
“While rainbow fentanyl may dominate the drug news cycle, there are other issues affecting opioid users that need more attention,” says Professor Leo Beletsky, faculty director of Health in Justice Action Lab.
It’s easy to think of diseases as ‘over there, them, we built a wall—problem solved.’ And that’s just not the way it works, especially with respiratory diseases,” cautions Professor Wendy Parmet, director of Northeastern Law's Center for Health Policy and Law.
“This is not a problem of passports and nationality. This is a problem about human beings,” says Professor Wendy Parmet, director of Northeastern Law's Center for Health Policy and Law. “Until the global community sees this as a global problem, that everybody needs to work together in terms of resources and dollars and having a coordinated response, then we’re going to have a problem.”
It’s the impulse to do something to combat the opioid crisis that has fueled the recent increase in drug-induced homicide prosecutions nationwide, Professor Leo Beletsky tells The Appeal. "These prosecutions take resources away from more effective interventions."
Respiratory diseases don't care about walls or immigration status,” Professor Wendy Parmet tells The American Independent. “If we think we can protect the public from COVID-19 or a similar outbreak by building a wall, we are in big trouble."
Although we can expect some pricing moderation by industry in response to the COVID-19 pandemic as it seeks to refurbish its tarnished reputation, the industry’s long-term goals are clear: more monopoly protections for a longer period of time and more opportunities to charge ever higher prices,"" cautions Professor Brook Baker in a piece for Health GAP. ""If industry succeeds, we will reap the consequences."
Will Disney fight back against Florida's law stripping the multinational conglomerate of its self-governing privileges? Professor Claudia Haupt explains why it might not be that easy.